Inventor · disambiguated record
Wilfried Dalemans
Also filed as: DALEMANS WILFRIED · DALEMANS WILFRIED L J · DALEMANS WILFRIED LJ
7 granted patents·15 pending applications·207 citations·filing 1993–2020
84Inventor score
Files withTIGENIX S A U7SMITHKLINE BEECHAM BIOLOG5GLAXOSMITHKLINE BIOLOG SA3LOMBARDO ELEUTERIO1TAKEDA PHARMACEUTICALS CO1
Top patents by PatentIndex Score
22 records- 0192US6013638AAdenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lungUS HEALTH·Filed 1993·Granted Jan 11, 2000·108 cites·14 claims
- 0285US6500432B1Method to enhance an immune response of nucleic acid vaccinationSMITHKLINE BEECHAM BIOLOG·Filed 1998·Granted Dec 31, 2002·64 cites·2 claims
- 0382US6136594AReplication deficient recombinant adenovirus vectorTRANSGENE SA·Filed 1995·Granted Oct 24, 2000·34 cites·15 claims
- 0467US10660920B2Lymphocyte biomarkers for determining the clinical response to cell therapyTIGENIX S A U·Filed 2014·Granted May 26, 2020·1 cites·16 claims
- 0561US11478511B2Lymphocyte biomarkers for determining the clinical response to cell therapyTIGENIX S A U·Filed 2020·Granted Oct 25, 2022·0 cites·16 claims
- 0658US2014294935A1Vaccine compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2014·Application pending·0 cites
- 0756US2008233154A1Vaccine CompositionSMITHKLINE BEECHAM BIOLOG·Filed 2006·Application pending·0 cites
- 0855US2006216307A1Vaccine compositionSMITHKLINE BEECHAM BIOLOG·Filed 2006·Application pending·0 cites
- 0954US2020376038A1Mesenchymal stromal cells for treating sepsisTIGENIX S A U·Filed 2020·Application pending·0 cites
- 1053US2002164304A1Adenovirus-mediated transfer of genes to the lungTRANSGENE·Filed 2001·Application pending·0 cites
- 1153US2009117147A1Vaccines comprising outer membrane vesicles from gram negative bacteriaGLAXOSMITHKLINE BIOLOG SA·Filed 2007·Application pending·0 cites
- 1252US2005031638A1VaccineSMITHKLINE BEECHAM BIOLOG·Filed 2004·Application pending·0 cites
- 1350US2016175423A1Vaccine compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2016·Application pending·0 cites
- 1446US2003072768A1Method to enhance an immune response of nucleic acid vaccinationSMITHKLINE BEECHAM BIOLOG·Filed 2002·Application pending·0 cites
- 1542US2004126389A1Vaccine compositionFiled 2001·Application pending·0 cites
- 1637US11857575B2Mesenchymal stem cell-derived exosomes and their usesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 2, 2024·0 cites·5 claims
- 1735US2017151284A1Mesenchymal stromal cells for treating sepsisTIGENIX S A U·Filed 2015·Application pending·0 cites
- 1833US2014154274A1Methods and compositions for use in intralymphatic cellular therapiesLOMBARDO ELEUTERIO·Filed 2012·Application pending·0 cites
- 1932US2017119682A1Mesenchymal stem cell-derived exosomes and their usesTIGENIX S A U·Filed 2016·Application pending·0 cites
- 2030US10746729B2Biomarkers for determining the clinical response to cell therapyTIGENIX SAU·Filed 2016·Granted Aug 18, 2020·0 cites·17 claims
- 2128US2017136065A1Mesenchymal stromal cells for treating rheumatoid arthritisTIGENIX S A U·Filed 2015·Application pending·0 cites
- 2224US2017121685A1Mesenchymal stem cell-derived exosomes and their usesTIGENIX S A U·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wilfried Dalemans files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →